Eye Diseases > Eyelids
Hordeolum (Stye)
Evidence-based assessment and management of hordeolum. Comprehensive guide covering etiology, pathogenesis, classification, diagnosis, and treatment protocols for optometry practice.
Hordeolum: External (Gland of Zeis/Moll) shown as red swelling on lid margin; Internal (Meibomian gland) within tarsal plate
A hordeolum, commonly known as a stye, is an acute, localized infection of the eyelid glands. It presents as a painful, erythematous nodule on the eyelid margin (external hordeolum) or within the tarsal plate (internal hordeolum). Hordeola are typically caused by bacterial infection, most commonly Staphylococcus aureus, and are one of the most frequent eyelid disorders encountered in clinical practice. While generally self-limiting, proper diagnosis and management are essential to prevent complications and recurrence.
Bacterial Causes
- Staphylococcus aureus: Most common causative organism (90–95% of cases)
- Staphylococcus epidermidis: Less common, particularly in recurrent cases
- Streptococcus species: Occasional causative agent
- Methicillin-resistant Staphylococcus aureus (MRSA): Increasing prevalence in some populations
Affected Glands by Type
External Hordeolum
- Glands of Zeis: Sebaceous glands at lash base
- Glands of Moll: Apocrine sweat glands near lashes
Internal Hordeolum
- Meibomian glands: Large sebaceous glands within tarsal plate
- More deeply seated and often more painful
Mechanism of Development
- Gland obstruction: Blockage of the gland orifice due to inspissated secretions, keratin debris, or inflammation prevents normal drainage
- Bacterial colonization: Stagnant secretions within the obstructed gland provide an ideal environment for bacterial proliferation, particularly S. aureus
- Acute inflammation: Bacterial multiplication triggers an acute inflammatory response with neutrophil infiltration
- Abscess formation: Accumulation of purulent material within the confined space of the gland leads to localized abscess formation
- Tissue pressure and pain: Increased pressure from the expanding abscess stretches the surrounding tissue, causing pain and swelling
- Resolution: Natural course typically involves spontaneous drainage (pointing and rupture) or gradual reabsorption with or without treatment
Key Point: Unlike chalazion (which is a chronic granulomatous inflammation), hordeolum is an acute suppurative (pus-forming) infection with active bacterial involvement.
| Type | Gland Involved | Location | Presentation |
|---|---|---|---|
| External Hordeolum | Zeis or Moll glands | Lid margin, anterior to tarsal plate | Visible pustule at lash base, points anteriorly |
| Internal Hordeolum | Meibomian glands | Within tarsal plate | Deeper swelling, may point to conjunctival surface |
External Hordeolum
- More common than internal type
- Smaller, more superficial
- Yellow pustule visible at lid margin
- Usually points and drains externally
- Generally less painful
- Resolves faster (3–7 days typically)
Internal Hordeolum
- Less common but more significant
- Larger, deeper within lid
- Yellow area seen on conjunctival surface when everted
- May point and drain onto conjunctiva
- More painful due to tarsal involvement
- May progress to chalazion if chronic
Local Risk Factors
- Chronic blepharitis: Ongoing lid margin inflammation
- Meibomian gland dysfunction (MGD): Abnormal gland secretions
- Seborrheic dermatitis: Increased sebum production
- Rosacea: Ocular rosacea with lid involvement
- Poor eyelid hygiene: Inadequate lid cleaning
- Eye rubbing: Mechanical irritation and bacterial introduction
- Contact lens wear: Especially with poor hygiene
- Eye makeup: Particularly sharing or using expired products
- Previous hordeolum: History of recurrent styes
Systemic Risk Factors
- Diabetes mellitus: Impaired immune function and wound healing
- Immunocompromised states: HIV/AIDS, immunosuppressive therapy
- Chronic stress: Decreased immune function
- Sleep deprivation: Compromised immune system
- Malnutrition: Vitamin deficiencies
- Nasal carriage of S. aureus: Source of recurrent infection
- Adolescence: Hormonal changes affecting sebaceous glands
- Smoking: Impaired circulation and immune response
Clinical Note: Recurrent hordeola warrant investigation for underlying conditions such as diabetes, immunodeficiency, or chronic blepharitis requiring ongoing management.
Primary Signs
- Localized swelling: Erythematous, tender nodule on eyelid
- Erythema: Redness of affected area and surrounding tissue
- Pustule formation: Yellow or white point indicating pus accumulation
- Lid margin involvement: Swelling focused at or near lash line
- Pointing: Abscess head forming toward skin or conjunctival surface
- Warmth: Localized heat on palpation
- Tenderness: Pain on gentle palpation
Associated Signs
- Eyelid edema: Diffuse swelling extending beyond lesion
- Conjunctival injection: Hyperemia of palpebral and bulbar conjunctiva
- Mucopurulent discharge: After spontaneous drainage
- Crusting: Dried secretions on lid margin and lashes
- Ipsilateral preauricular lymphadenopathy: In severe cases
- Secondary blepharitis: Lid margin inflammation
Examination Findings by Location
External Hordeolum
- Visible pustule at lash follicle base
- Centered on lid margin
- Points anteriorly through skin
- May see associated lash loss
Internal Hordeolum
- Yellow elevation on everted conjunctival surface
- Deeper lid swelling, less visible externally
- May point through palpebral conjunctiva
- Vertical lid swelling along meibomian gland
- Localized pain: Acute onset, throbbing pain at affected site
- Tenderness: Pain worsening with touch, blinking, or eye movement
- Foreign body sensation: Feeling of something in the eye
- Eyelid heaviness: Sensation of swollen, weighted eyelid
- Tearing: Reflex lacrimation from irritation
- Photophobia: Light sensitivity, especially in severe cases
- Blurred vision: Temporary, from eyelid swelling or tear film disruption
- Redness: Patient-noted lid and eye redness
- Discharge: Purulent discharge if ruptured
- Crusting: Morning mattering and stuck eyelids
- Itching: Mild to moderate, especially with associated blepharitis
Symptom Timeline: Symptoms typically develop rapidly over 1–2 days, peak at 3–5 days, and begin resolving by day 7–10 even without intervention. Persistent symptoms beyond 2 weeks suggest alternative diagnosis (e.g., chalazion, neoplasm).
Local Complications
- Chalazion formation: Chronic granulomatous inflammation if infection resolves but obstruction persists
- Preseptal cellulitis: Spread of infection to periorbital tissues anterior to orbital septum
- Orbital cellulitis: Rare but serious spread posterior to orbital septum (medical emergency)
- Abscess formation: Larger, more organized collection requiring drainage
- Chronic blepharitis: Ongoing lid margin inflammation
- Recurrent hordeola: Multiple episodes at same or different sites
- Lid scarring: From recurrent infections or surgical intervention
- Madarosis: Permanent lash loss at affected follicle
- Conjunctivitis: Secondary bacterial or reactive conjunctivitis
- Corneal involvement: Rare punctate keratitis from toxins
Rare Severe Complications
- Cavernous sinus thrombosis: Extremely rare but life-threatening
- Meningitis: From retrograde spread
- Brain abscess: Via septic emboli
- Septicemia: Systemic bacterial spread
Warning Signs Requiring Urgent Referral: Fever, severe periorbital edema, proptosis, ophthalmoplegia, decreased vision, severe pain, or systemically unwell patient. These suggest orbital or systemic spread requiring immediate ophthalmology consultation and possible hospitalization.
Associated Systemic Conditions
- Diabetes mellitus: Both a risk factor and should be screened for in recurrent cases
- Rosacea: Systemic inflammatory condition with ocular manifestations
- Seborrheic dermatitis: Chronic skin condition affecting sebaceous glands
- Atopic dermatitis: Associated with increased bacterial colonization
- Immunodeficiency states: HIV/AIDS, chemotherapy, organ transplant patients
- Hyperlipidemia: Altered lipid metabolism affecting meibomian glands
Screening Recommendations for Recurrent Hordeola
- Fasting blood glucose/HbA1c: Screen for diabetes mellitus
- Complete blood count: Assess immune function
- Lipid profile: Evaluate for dyslipidemia
- HIV screening: In high-risk populations or unexplained recurrence
- Nasal culture: For S. aureus carriage in recurrent cases
Clinical Pearl: While isolated hordeola rarely indicate systemic disease, recurrent or bilateral cases warrant investigation for underlying conditions, particularly diabetes and immunocompromise. Consider systemic workup if patient has 3 or more episodes in 12 months.
Clinical Diagnosis
Diagnosis is primarily clinical based on history and slit-lamp examination. Laboratory investigations are rarely required for uncomplicated cases.
History Taking
- Onset and duration of symptoms
- Pain characteristics (acute, localized, throbbing)
- Previous episodes of hordeola or chalazia
- Associated blepharitis or MGD
- Recent eye rubbing or trauma
- Contact lens wear and hygiene practices
- Cosmetic use and sharing
- Medical history: diabetes, immunosuppression, skin conditions
- Current medications
Slit-Lamp Examination
External examination:
- Localize swelling (upper/lower lid, medial/central/lateral)
- Assess size, erythema, and pointing
- Check for multiple lesions
- Note any lid deformity or scarring
Lid margin assessment:
- Inspect lash follicles
- Evaluate meibomian gland orifices
- Check for signs of chronic blepharitis
- Note quality and expressibility of meibum
Lid eversion:
- For internal hordeolum: yellow elevation on palpebral conjunctiva
- Assess degree of inflammation
- Rule out concurrent chalazion or other pathology
Imaging indications:
- B-scan ultrasound: For deep anterior orbital involvement or to localise a pointing abscess prior to drainage
- CT orbit (axial + coronal): If proptosis, restricted motility, or severe lid oedema suggests orbital cellulitis or subperiosteal abscess
- MRI orbit/brain: For cavernous sinus thrombosis or intracranial extension in severe cases
Severity Classification
| Category | Features | Severity |
|---|---|---|
| External hordeolum (stye) | Zeis or Moll gland; pointing anterior to lash line | Mild |
| Internal hordeolum | Meibomian gland; pointing through tarsal conjunctiva | Moderate |
| Preseptal cellulitis | Diffuse lid swelling, erythema, no proptosis/EOM restriction | Severe — refer urgently |
| Orbital cellulitis | Proptosis, pain on eye movement, ophthalmoplegia, reduced VA, fever | Critical — emergency |
Singapore Optometry Scope Note: Optometrists can diagnose hordeolum, educate patients on conservative treatment (warm compresses, lid hygiene), and monitor progress. Prescription of topical or systemic antibiotics requires referral to ophthalmology or a medical practitioner. Cases requiring incision and drainage or showing signs of preseptal cellulitis should be referred to ophthalmology.
Conservative Management (First-line)
Most hordeola resolve spontaneously within 7–10 days with conservative treatment.
1. Warm Compresses
- Apply warm, moist compress for 10–15 minutes, 4 times daily
- Temperature: comfortably warm, not scalding (40–45 degrees C)
- Promotes spontaneous drainage and increases blood flow
- Continue for 2–3 days after resolution
2. Lid Hygiene
- Clean lid margins with diluted baby shampoo or commercial lid scrub
- Twice daily during acute phase
- Prevents secondary infection and recurrence
- Continue as maintenance if chronic blepharitis present
3. Patient Education
- Avoid squeezing or attempting to drain the hordeolum
- Do not wear contact lenses until resolved
- Avoid eye makeup until completely healed
- Do not share towels, washcloths, or cosmetics
- Practice good hand hygiene
Medical Management
Topical Antibiotics
Indications: Large lesions, signs of spreading cellulitis, or failure to improve with conservative treatment after 48–72 hours
- Erythromycin 0.5% ointment: Apply to affected lid margin 2–4 times daily for 7–10 days
- Bacitracin-polymyxin B ointment: Alternative option, same dosing
- Fusidic acid 1% gel: Twice daily for 7 days
- Chloramphenicol 1% ointment: Alternative, 4 times daily for 5–7 days
Systemic Antibiotics
Indications: Preseptal cellulitis, recurrent hordeola, or immunocompromised patients
- Dicloxacillin 250–500 mg PO four times daily for 7–10 days (first-line for S. aureus)
- Cephalexin 250–500 mg PO four times daily for 7–10 days (alternative)
- If MRSA suspected: Doxycycline 100 mg PO twice daily or trimethoprim-sulfamethoxazole DS twice daily for 7–10 days
- Penicillin allergy: Clindamycin 300 mg PO three times daily for 7–10 days
Surgical Management
Incision and Drainage (I&D)
Indications:
- Pointing abscess with fluctuance
- Failure to respond to conservative treatment after 5–7 days
- Large, painful hordeolum affecting vision or causing significant discomfort
- Patient request for expedited resolution
Procedure (typically performed by ophthalmologist):
- Local anesthesia (lidocaine with epinephrine)
- External hordeolum: Incision through skin parallel to lid margin
- Internal hordeolum: Incision through palpebral conjunctiva perpendicular to lid margin
- Express purulent material; curettage of abscess cavity may be performed
- Post-procedure: topical antibiotic ointment
Treatment Selection Guide
| Presentation | Recommended Approach |
|---|---|
| Early/small external hordeolum | Warm compresses + lid hygiene; observe 7–14 days |
| Non-resolving or large lesion | Add topical antibiotics; refer if not improving in 48–72 hours |
| Pointing abscess | Refer for incision and drainage |
| Preseptal cellulitis | Systemic antibiotics + urgent ophthalmology referral |
| Orbital cellulitis | Emergency hospital admission (call 995 or send to A&E) |
Refer to Ophthalmology for:
- Preseptal or orbital cellulitis
- No improvement after 48–72 hours of appropriate antibiotic therapy
- Proptosis, restricted eye movement, or reduced visual acuity
- Fever, severe pain, or systemically unwell patient
- Recurrent hordeola (3 or more episodes in 12 months)
- Lesion requiring incision and drainage
- Suspected malignancy (persistent lesion more than 6 weeks)
- Immunocompromised patient with severe presentation
General Prognosis
- Excellent overall prognosis: Most hordeola resolve completely without long-term sequelae
- Self-limiting: Majority spontaneously drain and resolve within 7–14 days even without treatment
- Accelerated resolution: Conservative measures (warm compresses) can reduce duration to 5–7 days
- Post-drainage: Rapid improvement within 24–48 hours after spontaneous or surgical drainage
- Visual prognosis: Excellent; permanent vision loss is extremely rare
Factors Affecting Prognosis
Favorable Factors
- Early initiation of warm compresses
- External hordeolum (vs. internal)
- Small lesion size
- Immunocompetent patient
- Good lid hygiene practices
- First episode (vs. recurrent)
- No underlying blepharitis or MGD
Unfavorable Factors
- Delayed treatment
- Internal hordeolum
- Large abscess formation
- Immunocompromised state
- Diabetes mellitus (especially uncontrolled)
- Recurrent episodes
- Chronic blepharitis or MGD
Expected Outcomes
- Complete resolution: 95–98% of cases with appropriate treatment
- Chalazion formation: 2–5% may progress to chronic granulomatous inflammation
- Recurrence rate: 10–15% will experience at least one recurrence
- Scarring: Minimal, typically not clinically significant
Several eyelid conditions can mimic hordeolum. Accurate differentiation is essential for appropriate management and to avoid missing serious pathology.
1. Chalazion
- Definition: Chronic, sterile granulomatous inflammation of meibomian gland
- Key differences: Not painful (vs. painful hordeolum), chronic onset (weeks), firm nodule, no active infection
- Management: Warm compresses, steroid injection, or surgical excision; antibiotics not typically needed
- Note: Hordeolum can progress to chalazion if infection resolves but obstruction persists
2. Preseptal Cellulitis
- Definition: Bacterial infection of eyelid and periorbital tissues anterior to orbital septum
- Key differences: Diffuse lid swelling and erythema (vs. localized nodule), may follow hordeolum, fever possible
- Management: Systemic antibiotics, close monitoring, possible hospitalization
3. Sebaceous Gland Carcinoma
- Definition: Malignant tumor of sebaceous glands (meibomian, Zeis)
- Key differences: Persistent/recurrent chalazion-like lesion unresponsive to treatment, painless, firm, may cause madarosis
- Red flags: Age over 50, unilateral, loss of lashes, lid margin distortion, fails to respond to treatment beyond 6 weeks
- Management: Biopsy essential, surgical excision with wide margins
4. Dacryoadenitis
- Definition: Inflammation of the lacrimal gland
- Key differences: Upper lateral lid swelling, S-shaped lid deformity, palpable lacrimal gland
- Etiology: Bacterial, viral, or inflammatory
5. Molluscum Contagiosum
- Definition: Viral infection (poxvirus) causing umbilicated nodules
- Key differences: Painless, multiple lesions possible, central umbilication
- Management: Excision, cryotherapy, or observation (self-limited)
Comparison Table
| Condition | Pain | Onset | Characteristics | Resolution |
|---|---|---|---|---|
| Hordeolum | Painful | Acute (1–2 days) | Tender, red, pustule | 7–14 days |
| Chalazion | Painless | Gradual (weeks) | Firm, non-tender nodule | Months or surgical |
| Preseptal Cellulitis | Painful | Acute | Diffuse lid swelling, fever | With antibiotics |
| Sebaceous Carcinoma | Painless | Very gradual | Persistent, madarosis | Surgical excision |
| Molluscum | Painless | Gradual | Umbilicated, viral | Self-limited or excision |
Red Flags Requiring Biopsy:
- Lesion persisting beyond 6 weeks despite appropriate treatment
- Recurrent chalazion-like lesion at same location
- Loss of eyelashes (madarosis)
- Distortion of lid margin or tissue destruction
- Unilateral chronic blepharitis unresponsive to treatment
- Patient age over 50 with atypical presentation
Warm compress temperature matters. 40–45 degrees C (comfortably warm, not scalding) for 10–15 minutes, 4 times daily. A compress that is too hot causes burns; too cool is ineffective. A reusable heat mask heated in a microwave is practical for home use.
Recurrent chalazion at the same site is sebaceous gland carcinoma until proven otherwise. Any chalazion not resolving in 6–8 weeks, or recurring at the identical site, must be referred for biopsy. This is one of the most important masquerade scenarios in eyelid disease.
Orbital cellulitis red flags: proptosis, restricted eye movement, diplopia, reduced visual acuity, severe lid oedema with fever, or chemosis. These require emergency hospital admission — do not manage in primary care.
Upper lid internal hordeolum can directly contact the cornea and cause punctate epithelial erosions. Always evert the upper lid on slit-lamp examination when there is unexplained inferior corneal staining.
Never squeeze a hordeolum. Squeezing can spread the infection to adjacent glands or into the preseptal space, converting a simple localized infection into a more serious cellulitis. Educate patients firmly that the only appropriate pressure is gentle warmth, not mechanical compression.
Treat the background, not just the lesion. Isolated hordeola are managed conservatively. Recurrent hordeola require treatment of the underlying risk factors: address blepharitis with ongoing lid hygiene, screen for diabetes, review eye makeup hygiene, and consider doxycycline for anti-inflammatory effect in MGD-driven recurrence.
Singapore Optometry Scope Note: Optometrists can initiate warm compresses and lid hygiene for hordeolum. Topical antibiotics require a prescription — refer for this. Systemic antibiotics (preseptal cellulitis) and incision and drainage require ophthalmology or emergency department referral. Orbital cellulitis is a medical emergency — call 995 or refer to A&E immediately.
- Lindsley K, Nichols JJ, Dickersin K. Non-surgical interventions for acute internal hordeolum. Cochrane Database Syst Rev. 2017;1(1):CD007742.
- Gilchrist H, Lee G. Management of chalazia in general practice. Aust Fam Physician. 2009;38(5):311-314.
- American Academy of Ophthalmology. Hordeolum and Chalazion. EyeWiki. Updated December 2023.
- Ben Simon GJ, Huang L, Nakra T, et al. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective? Ophthalmology. 2005;112(5):913-917.
- Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984;68(8):524-528.
- Carlisle RT, Digiovanni J. Differential diagnosis of the swollen red eyelid. Am Fam Physician. 2015;92(2):106-112.
- Benevides S, Goldberg RA, Shorr N. Hordeolum, chalazion, and blepharitis. In: Tasman W, Jaeger EA, eds. Duane’s Foundations of Clinical Ophthalmology. Lippincott Williams & Wilkins; 2013.
- Viswalingam M, Rauz S, Morlet N, Dart JK. Blepharokeratoconjunctivitis in children: diagnosis and treatment. Br J Ophthalmol. 2005;89(4):400-403.
- Mueller JB, McStay CM. Ocular infection and inflammation. Emerg Med Clin North Am. 2008;26(1):57-72.
- Buzney E, Shyam J, Friedman D, Rubin P. Sebaceous carcinoma of the eyelid: 5 cases and a review of the literature. Surv Ophthalmol. 2007;52(2):149-162.
- Skorin L Jr, Keirn MM. Hordeolum and chalazion. Dis Mon. 1997;43(11):741-817.
- Huerva V, Sanchez MC, Traveset A, et al. Eyelid hygiene in chronic blepharitis. Arch Soc Esp Oftalmol. 2006;81(4):191-196.
- Bernardini FP. Management of malignant and benign eyelid lesions. Curr Opin Ophthalmol. 2006;17(5):480-484.
- Gao YY, Di Pascuale MA, Li W, et al. High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005;46(9):3089-3094.
- Athanasiov PA, Prabhakaran VC, Selva D. Non-traumatic enophthalmos: a review. Acta Ophthalmol. 2008;86(4):356-364.